Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of PicnicHealth.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
PicnicHealth
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
2519 Mission St, San Francisco, CA 94110
Telephone
Telephone
(415) 801-0572

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

CAMZYOS (mavacamten) is the first and only FDA-approved allosteric and reversible inhibitor selective for cardiac myosin that targets the underlying pathophysiology of obstructive HCM.


Lead Product(s): Mavacamten

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Camzyos

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Bristol Myers Squibb

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 10, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Following initial efforts focused on multiple sclerosis (MS), PicnicHealth, Roche and Genentech recently expanded their collaboration to support Huntington’s disease (HD), paroxysmal nocturnal hemoglobinuria (PNH), and hemophilia.


Lead Product(s): Undisclosed

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Undisclosed

Partner/Sponsor/Collaborator: F. Hoffmann-La Roche

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership July 17, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY